(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -16.62%782.76M | 55.58%450.61M | 6.21%938.76M | -44.29%289.64M | -21.71%883.91M | -20.99%519.89M | 65.88%1.13B | 336.95%658.02M | 139.24%680.6M | 3.96%150.59M |
Operating income | -16.62%782.76M | 55.58%450.61M | 6.21%938.76M | -44.29%289.64M | -21.71%883.91M | -20.99%519.89M | 65.88%1.13B | 336.95%658.02M | 139.24%680.6M | 3.96%150.59M |
Cost of sales | 19.62%-464.71M | -63.69%-281.38M | -19.61%-578.13M | 38.53%-171.9M | 30.91%-483.35M | 31.36%-279.67M | -119.69%-699.62M | -852.34%-407.43M | -182.29%-318.45M | 37.24%-42.78M |
Operating expenses | 19.62%-464.71M | -63.69%-281.38M | -19.61%-578.13M | 38.53%-171.9M | 30.91%-483.35M | 31.36%-279.67M | -119.69%-699.62M | -852.34%-407.43M | -182.29%-318.45M | 37.24%-42.78M |
Gross profit | -11.81%318.05M | 43.73%169.23M | -9.97%360.63M | -50.99%117.74M | -6.71%400.56M | -4.14%240.22M | 18.56%429.35M | 132.43%250.59M | 110.95%362.15M | 40.56%107.81M |
Selling expenses | 22.09%-63.73M | -28.50%-40.45M | 22.19%-81.8M | 52.61%-31.48M | -78.75%-105.13M | -134.87%-66.43M | 23.87%-58.81M | -40.50%-28.29M | -11.55%-77.25M | 31.59%-20.13M |
Administrative expenses | 15.28%-76.18M | 10.15%-41.95M | 1.68%-89.92M | -17.82%-46.69M | -62.62%-91.46M | -46.68%-39.63M | -6.31%-56.24M | -4.90%-27.01M | -4.86%-52.9M | 8.99%-25.75M |
Research and development expenses | -0.49%-231.14M | -20.45%-126.43M | -32.73%-230.02M | -27.28%-104.96M | -62.74%-173.3M | -80.80%-82.46M | -9.71%-106.49M | -2.34%-45.61M | -19.26%-97.06M | -15.18%-44.57M |
Profit from asset sales | ---- | ---- | ---- | ---- | -110.64%-6.96M | ---- | 799.33%65.42M | ---- | -93.68%7.27M | -93.68%7.27M |
Impairment and provision | -273.39%-4M | -31,300.00%-312K | 16.59%-1.07M | -99.75%1K | -86.90%-1.28M | 217.80%397K | 74.26%-687K | 92.00%-337K | -154.92%-2.67M | -332.65%-4.21M |
-Other impairment is provision | -273.39%-4M | -31,300.00%-312K | 16.59%-1.07M | -99.75%1K | -86.90%-1.28M | 217.80%397K | 74.26%-687K | 92.00%-337K | -154.92%-2.67M | -332.65%-4.21M |
Special items of operating profit | -63.36%1.87M | -71.35%1.01M | -29.80%5.11M | -28.39%3.51M | -19.93%7.27M | 116.67%4.9M | -55.25%9.09M | -77.47%2.26M | -8.35%20.3M | 57.64%10.04M |
Operating profit | -48.66%-55.13M | 37.13%-38.91M | -224.83%-37.08M | -208.58%-61.88M | -89.45%29.71M | -62.40%57M | 76.19%281.62M | 397.75%151.6M | 49.79%159.84M | -69.75%30.46M |
Financing income | -18.26%35.43M | 2.86%22.54M | 30.35%43.34M | 46.07%21.91M | 39.15%33.25M | 13.73%15M | 16.24%23.9M | 48.64%13.19M | -24.97%20.56M | -49.08%8.87M |
Financing cost | 33.07%-2.43M | 23.02%-1.48M | 57.38%-3.63M | 18.99%-1.92M | 33.12%-8.51M | 15.39%-2.37M | -111.98%-12.72M | 8.73%-2.8M | -8,856.72%-6M | -4,480.60%-3.07M |
Share of profits of associates | ---1.3M | ---- | ---- | ---- | 5.61%-3.12M | -57.56%-2.41M | 81.81%-3.3M | 90.05%-1.53M | -156.02%-18.14M | -796.55%-15.34M |
Earning before tax | -989.11%-23.43M | 57.40%-17.85M | -94.87%2.64M | -162.32%-41.89M | -82.27%51.33M | -58.11%67.22M | 85.28%289.5M | 666.99%160.46M | 23.08%156.25M | -82.02%20.92M |
Tax | -203.50%-7.97M | -201.27%-2.07M | 131.54%7.7M | 109.73%2.04M | -50.16%-24.43M | -126.10%-20.98M | -220.05%-16.27M | -1,210.45%-9.28M | 71.66%-5.08M | 96.33%-708K |
After-tax profit from continuing operations | -403.72%-31.4M | 50.03%-19.91M | -61.57%10.34M | -186.18%-39.85M | -90.15%26.91M | -69.41%46.24M | 80.75%273.23M | 647.95%151.18M | 38.66%151.17M | -79.17%20.21M |
Earning after tax | -403.72%-31.4M | 50.03%-19.91M | -61.57%10.34M | -186.18%-39.85M | -90.15%26.91M | -69.41%46.24M | 80.75%273.23M | 647.95%151.18M | 40.43%151.17M | -78.74%20.21M |
Minority profit | -55.81%76K | -2.60%75K | -63.48%172K | 260.42%77K | 149.11%471K | 81.25%-48K | -109.39%-959K | -111.57%-256K | 89.65%-458K | 97.23%-121K |
Profit attributable to shareholders | -409.61%-31.48M | 49.94%-19.99M | -61.54%10.17M | -186.26%-39.93M | -90.36%26.44M | -69.43%46.29M | 80.83%274.19M | 644.76%151.44M | 35.29%151.63M | -79.55%20.33M |
Basic earnings per share | -400.00%-0.0117 | 50.66%-0.0075 | -61.39%0.0039 | -185.88%-0.0152 | -90.29%0.0101 | -69.00%0.0177 | 83.75%0.104 | 661.33%0.0571 | 38.39%0.0566 | -79.22%0.0075 |
Diluted earnings per share | -407.89%-0.0117 | 50.66%-0.0075 | -61.62%0.0038 | -187.86%-0.0152 | -90.43%0.0099 | -69.70%0.0173 | 82.69%0.1034 | 661.33%0.0571 | 38.73%0.0566 | -79.11%0.0075 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data